Bernardini, F.; Nusca, A.; Coletti, F.; La Porta, Y.; Piscione, M.; Vespasiano, F.; Mangiacapra, F.; Ricottini, E.; Melfi, R.; Cavallari, I.;
et al. Incretins-Based Therapies and Their Cardiovascular Effects: New Game-Changers for the Management of Patients with Diabetes and Cardiovascular Disease. Pharmaceutics 2023, 15, 1858.
https://doi.org/10.3390/pharmaceutics15071858
AMA Style
Bernardini F, Nusca A, Coletti F, La Porta Y, Piscione M, Vespasiano F, Mangiacapra F, Ricottini E, Melfi R, Cavallari I,
et al. Incretins-Based Therapies and Their Cardiovascular Effects: New Game-Changers for the Management of Patients with Diabetes and Cardiovascular Disease. Pharmaceutics. 2023; 15(7):1858.
https://doi.org/10.3390/pharmaceutics15071858
Chicago/Turabian Style
Bernardini, Federico, Annunziata Nusca, Federica Coletti, Ylenia La Porta, Mariagrazia Piscione, Francesca Vespasiano, Fabio Mangiacapra, Elisabetta Ricottini, Rosetta Melfi, Ilaria Cavallari,
and et al. 2023. "Incretins-Based Therapies and Their Cardiovascular Effects: New Game-Changers for the Management of Patients with Diabetes and Cardiovascular Disease" Pharmaceutics 15, no. 7: 1858.
https://doi.org/10.3390/pharmaceutics15071858
APA Style
Bernardini, F., Nusca, A., Coletti, F., La Porta, Y., Piscione, M., Vespasiano, F., Mangiacapra, F., Ricottini, E., Melfi, R., Cavallari, I., Ussia, G. P., & Grigioni, F.
(2023). Incretins-Based Therapies and Their Cardiovascular Effects: New Game-Changers for the Management of Patients with Diabetes and Cardiovascular Disease. Pharmaceutics, 15(7), 1858.
https://doi.org/10.3390/pharmaceutics15071858
